20 February 2026 in Prostate Cancer and Prostatic Diseases
Introduction: Telesurgery represents an emerging frontier in the surgical management of prostate cancer, offering innovative solutions to expand access to specialized care across geographic and institutional barriers. This systematic review aims to evaluate the feasibility, clinical outcomes, and technical considerations of telesurgical applications in the treatment of prostate cancer. Methods: A comprehensive literature search was conducted across MEDLINE (via PubMed), Embase, Scopus, and Web of Science in June 2025 to identify all consecutive clinical studies published from 2001 through June 2025 that involved telesurgical approaches for the management of clinically significant, localized prostate cancer. Eligible studies were screened and reviewed according to PRISMA guidelines, and a narrative synthesis was performed. Results: A total of six studies met the inclusion criteria, demonstrating successful telesurgical procedures involving 7 patients, with six procedures pertaining to Robot-Assisted Radical Prostatectomy (RARP) and one case of High-Intensity Focused Ultrasound (HIFU) focal therapy. All procedures were completed successfully over distances ranging between 1 and 11,412 km. The most commonly utilized network infrastructure included 5 G wireless and wired fiber-optic broadband systems. With a round-trip latency ranging between 6 ms and 464 ms, no technical failures and no clinically meaningful delays perceived by the surgeons were reported. Conclusions: Herein, we demonstrated the feasibility and safety of radical and focal robotic telesurgical procedures for the management of prostate cancer. Despite its successes and benefits in democratizing patient care and surgical education, challenges surrounding its cost, regulatory frameworks, and standardization of care may continue to pose limitations, underscoring the need for further research and policy innovation.
6 January 2026 in Journal of Plastic, Reconstructive & Aesthetic Surgery
17 May 2026 in Journal of Endourology
Objective: To develop and internally validate a machine-learning-based nomogram for predicting trifecta achievement in patients undergoing robot-assisted partial nephrectomy (RAPN). Materials and Methods: This retrospective single-center study included 426 patients who underwent RAPN between 2011 and 2025 years. Trifecta was defined as negative surgical margins, warm ischemia time ≤25 minutes, and absence of perioperative complications. Variable selection was performed using the Least Absolute Shrinkage and Selection Operator (LASSO) logistic regression. Selected predictors were incorporated into a multivariate logistic regression model to construct a nomogram. Model performance was assessed using discrimination, calibration, and decision-curve analysis (DCA) with internal bootstrap validation. Results: Trifecta was achieved in 87.7% of patients. The total operative time, estimated blood loss, tumor location, collecting system entry, and need for perioperative blood transfusion were identified as independent predictors. The model demonstrated good discrimination (area under the curve = 0.792, 95% confidence interval: 0.738–0.845). Calibration was acceptable (bootstrap–corrected slope 0.91, intercept 0.13), and the DCA showed a higher net benefit than treat-all/none for thresholds of ∼0.10–0.75. Conclusions: This LASSO-based nomogram offers individualized and clinically interpretable prediction of trifecta achievement in RAPN. Integrating key surgical and tumor–related parameters has the potential to support perioperative decision-making and patient counseling. External validation through prospective multicenter studies is warranted to confirm its generalizability and facilitate clinical implementation.
24 August 2024 in Journal of Minimally Invasive Gynecology